HomeHealthcare & Life SciencesPharmaceuticals Bioidentical Hormones Market

China Bioidentical Hormones Market Size & Outlook, 2025-2033


China Bioidentical Hormones Market Insights

  • As highlighted in Reed Intelligence analysis, the China Bioidentical Hormones Market, worth USD 372.39 Million in 2024, is forecasted to achieve USD 624.4 Million by 2033.
  • The China market is anticipated to grow at a CAGR of 5.95% during the period 2026–2033.
  • By 2024, Estrogens represented the largest share of the By Type market size.
  • Others is expected to remain the key growth driver within By Type, registering the fastest CAGR during the forecast period.

Other Key Findings


  • In 2024, China accounted for 10.34% of the global Bioidentical Hormones Market size.
  • By 2033, United States is expected to lead the global Bioidentical Hormones Market in terms of market size.
  • Within Asia Pacific, China is projected to dominate the regional Bioidentical Hormones Market size by 2033.
  • Japan is identified as the fastest-growing market in Asia Pacific, anticipated to reach USD 202.29 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 372.39 Million
Market Size In 2033 USD 624.4 Million
Largest segment Estrogens
Units Revenue in USD Million
CAGR 5.95% (2025-2033)
Segmnetation Covered
By Type
  1. Estrogens
  2. Progesterone
  3. Testosterone
  4. Others
By Form
  1. Tablets and capsules
  2. Creams and gels
  3. Injectables
  4. Patches and implants
  5. Others
By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
By End-use
  1. Hospitals
  2. Gynecology clinics
  3. Research laboratories
  4. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports